Ketorolac tromethamine

This classification denotes a cyclooxygenase inhibitor with the molecular formula C15H13NO3.C4H11NO3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 4EVE5946BQ, chemically known as 1h-pyrrolizine-1-carboxylic acid, 5-benzoyl-2,3-dihydro, (+-)-, compound with 2-amino-2-(hydroxymethyl)-1,3-propanediol (1:1) but more generally known as ketorolac trometamol, which bears US NIH Compound Identifier 84003. European Medicines Agency schedules Ketorolac trometamol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB02835MIG. Most nations, for tariff and trade purposes, schedule ketorolac tromethamine under HS 29339990 and SITC 51577. As of Q4 2014, KETOROLAC TROMETHAMINE remains US FDA's Preferred Term for this commodity. Ketorolac tromethamine bears US NLM identifiers UMLS ID C0146226 and NCI Concept Code C61798. SMILES: C1CCC(CC1)C(=O)C2CCC3N2CCC3C(=O)O.C(C(CO)(CO)N)O.